Recent research comparing gastroparesis risk across weight loss modalities found semaglutide users without diabetes had higher gastroparesis incidence compared to those using other weight loss medications or undergoing bariatric surgery
Statistical analysis GraphPad Prism 10 (GraphPad Software, La Jolla, CA, USA) was used for statistical analysis
During mitochondrial dysfunction, Nrf2 is typically inhibited by Keap1, which stabilizes the complex and prevents Nrf2 activation
This condition can stem from genetic factors, selenium shortages, or other underlying issues, resulting in a buildup of reactive oxygen species that damage cells over time
For instance, if you have Type 2 diabetes, which was the first condition for which GLP-1 drugs were approved by the U.S
Semaglutide activates GLP-1 receptors approximately three times more effectively than liraglutide